Pancreatic carcinoma has a dismal prognosis. In the last years, great effor
ts have been made to improve diagnosis and preoperative staging of potentia
lly curable carcinomas. Actually, the diagnosis of fairly small tumours is
possible. Chemoradiation therapy protocols prior to pancreatectomy, aiming
to improve survival, are currently being held. This therapy allows radiatio
n to be distributed into well oxygenated cells before surgical devasculariz
ation. This procedure can be done with acceptable morbidity and mortality r
ates. In selected cases of irresectable carcinoma, surgical palliation allo
ws a better quality of life. Pancreatoduodenal resection, along with other
traditional oncological therapies, will continue to be the therapy of choic
e for patients with carcinoma of the head of the pancreas, without local or
regional metastases. However, an intensive search for new therapeutic stra
tegies, specially in the field of molecular biology, is being carried out.